Saturn V Capital Management LP

AUSTIN, TX · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$683.1M2026 Q3
Positions24
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.72.6%

Saturn V Capital Management LP reported 24 positions worth $683.1M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: AMLX (19.0%).

10 / 24 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 AMLXAmylyx Pharmaceuticals$130.1M19.05%4,471,356——-4.5%
▸ 2 ABVXAbivax S.A.$52.4M7.67%529,313———
▸ 3 IMMXImmix Biopharma$48.5M7.10%4,661,115———
▸ 4 PHVSPharvaris N.V.$44.2M6.47%1,393,956——+2.3%
▸ 5 PCVXVaxcyte$43.9M6.43%772,258——+8.3%
▸ 6 CELCCelcuity$40.9M5.98%513,847——-23.8%
▸ 7 IRONDisc Medicine$40.1M5.87%612,661——+17.0%
▸ 8 CADLCandel Therapeutics$36.3M5.31%3,476,206——-40.6%
▸ 9 JAZZJazz Pharmaceuticals$34.8M5.10%150,340——+3.6%
▸ 10 MNPRMonopar Therapeutics$24.9M3.64%312,350——-9.7%

Pro Feature

The remaining 14 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Saturn V Capital Management LP hold as of Q3 2026?

Saturn V Capital Management LP reported 24 positions worth $683.1M in its Q3 2026 13F filing. Largest positions: AMLX (19.0%), ABVX (7.7%), IMMX (7.1%), PHVS (6.5%) and PCVX (6.4%).

What did Saturn V Capital Management LP buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Saturn V Capital Management LP sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.